Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen
Event: Frontiers in CardioVascular Biomedicine 2024
Topic: Drugs, Drug Targets
Session: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy
